about
Palliative medicine and decision science: the critical need for a shared agenda to foster informed patient choice in serious illnessPredictors of Physical Restraint Use in Hospitalized Veterans at End of Life: An Analysis of Data from the BEACON Trial.Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapyTranslating and testing the ENABLE: CHF-PC concurrent palliative care model for older adults with heart failure and their family caregiversDeveloping successful models of cancer palliative care servicesEarly Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial.Conceptualizing surrogate decision making at end of life in the intensive care unit using cognitive task analysis.Joint modeling quality of life and survival using a terminal decline model in palliative care studies.Proxy perspectives regarding end-of-life care for persons with cancer.Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.Patient perspectives on participation in the ENABLE II randomized controlled trial of a concurrent oncology palliative care intervention: benefits and burdensOncologists' perspectives on concurrent palliative care in a National Cancer Institute-designated comprehensive cancer centerPutting evidence into practice: what are the pharmacologic interventions for nociceptive and neuropathic cancer pain in adults?.Bowel obstruction and delirium: managing difficult symptoms at the end of life.Formative research in the development of a care transition intervention in breast cancer survivors.Using quality improvement methodology to improve neuropathic pain screening and assessment in patients with cancer.Priorities for Evaluating Palliative Care Outcomes in Intensive Care Units.Engaging patients and families to create a feasible clinical trial integrating palliative and heart failure care: results of the ENABLE CHF-PC pilot clinical trial.Project ENABLE: a palliative care demonstration project for advanced cancer patients in three settings.Background noise: the experience of chemotherapy-induced peripheral neuropathy.Incongruence between women's survey- and interview-determined decision control preferences: A mixed methods study of decision-making in metastatic breast cancerEducate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers (ENABLE CHF-PC): study protocol for a randomized controlled trialThe analysis and interpretation of cognitive interviews for instrument developmentPalliative care program effectiveness research: developing rigor in sampling design, conduct, and reportingHas there been any progress in improving the quality of hospitalised death? Replication of a US chart audit study
P50
Q24629373-4D169F40-8D74-4FB6-BE2F-72523061B506Q30941152-2F7CB104-036A-4AE2-81B0-C5CFE7DBF2D7Q34049891-EFA8971B-2689-4EE6-BEF9-9DE79F120EDFQ34154621-39FD24AB-2CA7-4346-BEAE-17A6970CEB1DQ34292288-30F49A9A-683C-4647-9E26-C5960D13F172Q35501644-654B6CDF-1222-4AD7-A530-5240C01B304AQ35501663-522CC205-4858-4024-A944-0CB8857833B8Q35626158-B3B1A43C-6C9F-45C2-9A96-9536BD3742C4Q36757485-BD6CA5F7-0C55-4F89-B5A1-5CA69E29C7F4Q36802836-A73B02C4-11F4-4476-B152-9F62D7A21999Q36854902-3CAFF602-EF3B-481C-8A4C-5E65EDF5E895Q36854907-0784D0C6-5013-4020-93AE-F2D60CDB32C5Q37230867-63477566-304B-43DE-BE46-D0D61D81D875Q37641514-90983230-B4F0-4CFF-BE55-207D9E7C9EB8Q38030369-F74BCB75-68D8-42BD-99EE-EAF0037E2C56Q38366213-614EF989-D48A-47DD-896F-49CB75816E61Q38436911-AC8E4CA3-5F28-41BB-86F7-A12B86250E61Q38579439-B0F9E938-32E7-4744-BB7E-0E23CD26DD33Q41588376-B11FD06F-374E-4BFD-8482-7FDEE56C2C8CQ50147695-3A80DCB3-0677-4628-B7B2-8EE671E7F7D9Q51899590-0840C31A-A0E9-42CD-A1BB-ED44809E6065Q57173545-022DD309-1D52-4CCD-9EA6-E27F46D2ABD9Q58798912-891AFC2A-2646-49A6-9CEC-A02F8094C5D6Q80021024-E6AAC875-810E-4631-821B-5E65BCDD7B25Q82964062-8309801C-962B-4F56-BE03-602977921731Q87487040-9B651A3E-5F39-4512-B25F-50574AC1E675
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marie Bakitas
@ast
Marie Bakitas
@en
Marie Bakitas
@es
Marie Bakitas
@nl
type
label
Marie Bakitas
@ast
Marie Bakitas
@en
Marie Bakitas
@es
Marie Bakitas
@nl
prefLabel
Marie Bakitas
@ast
Marie Bakitas
@en
Marie Bakitas
@es
Marie Bakitas
@nl
P106
P1153
8545485200
P31
P496
0000-0002-2913-2053